Rubella Virus Capsid Protein Modulation of Viral Genomic and Subgenomic RNA Synthesis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
On the Entry and Entrapment of Picornaviruses
On the entry and entrapment of picornaviruses Jacqueline Staring PS_JS_def.indd 1 08-10-18 08:46 ISBN 978-94-92679-60-4 NUR 100 Printing and lay-out by: Proefschriftenprinten.nl – The Netherlands With financial support from the Netherlands Cancer Institute © J. Staring, 2018 All rights are reserved. No part of this book may be reproduced, distributed, or transmitted in any form or by any means, without prior written permission of the author. PS_JS_def.indd 2 08-10-18 08:46 On the entry and entrapment of picornaviruses Over het binnendringen en insluiten van picornavirussen (met een samenvatting in het Nederlands) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof. dr. H.R.B.M. Kummeling, ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op dinsdag 6 november 2018 des middags te 16.15 uur door Jacqueline Staring geboren op 8 december 1984 te Leiden PS_JS_def.indd 3 08-10-18 08:46 Promotor: Prof. dr T.R. Brummelkamp PS_JS_def.indd 4 08-10-18 08:46 TABLE OF CONTENTS Chapter 1 Introduction I: Picornaviruses 7 Chapter 2 Introduction II: Genetic approaches to study 27 host-pathogen interactions Chapter 3 PLA2G16, a switch between entry and clearance of 43 picornaviridae Chapter 4 Enterovirus D68 receptor requirements unveiled by 77 haploid genetics Chapter 5 KREMEN1 is a host entry receptor for a major group 95 of enteroviruses Chapter 6 General Discussion I: Viral endosomal escape & 125 detection at a glance Chapter 7 General Discussion II: Concluding remarks 151 Addendum 161 Summary 163 Nederlandse samenvatting 165 Curriculum vitae 167 List of publications 168 Acknowledgements 169 PS_JS_def.indd 5 08-10-18 08:46 Roll the dice if you’re going to try, go all the way. -
Comparative Analysis, Distribution, and Characterization of Microsatellites in Orf Virus Genome
www.nature.com/scientificreports OPEN Comparative analysis, distribution, and characterization of microsatellites in Orf virus genome Basanta Pravas Sahu1, Prativa Majee 1, Ravi Raj Singh1, Anjan Sahoo2 & Debasis Nayak 1* Genome-wide in-silico identifcation of microsatellites or simple sequence repeats (SSRs) in the Orf virus (ORFV), the causative agent of contagious ecthyma has been carried out to investigate the type, distribution and its potential role in the genome evolution. We have investigated eleven ORFV strains, which resulted in the presence of 1,036–1,181 microsatellites per strain. The further screening revealed the presence of 83–107 compound SSRs (cSSRs) per genome. Our analysis indicates the dinucleotide (76.9%) repeats to be the most abundant, followed by trinucleotide (17.7%), mononucleotide (4.9%), tetranucleotide (0.4%) and hexanucleotide (0.2%) repeats. The Relative Abundance (RA) and Relative Density (RD) of these SSRs varied between 7.6–8.4 and 53.0–59.5 bp/ kb, respectively. While in the case of cSSRs, the RA and RD ranged from 0.6–0.8 and 12.1–17.0 bp/kb, respectively. Regression analysis of all parameters like the incident of SSRs, RA, and RD signifcantly correlated with the GC content. But in a case of genome size, except incident SSRs, all other parameters were non-signifcantly correlated. Nearly all cSSRs were composed of two microsatellites, which showed no biasedness to a particular motif. Motif duplication pattern, such as, (C)-x-(C), (TG)- x-(TG), (AT)-x-(AT), (TC)- x-(TC) and self-complementary motifs, such as (GC)-x-(CG), (TC)-x-(AG), (GT)-x-(CA) and (TC)-x-(AG) were observed in the cSSRs. -
Characterization of the Rubella Virus Nonstructural Protease Domain and Its Cleavage Site
JOURNAL OF VIROLOGY, July 1996, p. 4707–4713 Vol. 70, No. 7 0022-538X/96/$04.0010 Copyright q 1996, American Society for Microbiology Characterization of the Rubella Virus Nonstructural Protease Domain and Its Cleavage Site 1 2 2 1 JUN-PING CHEN, JAMES H. STRAUSS, ELLEN G. STRAUSS, AND TERYL K. FREY * Department of Biology, Georgia State University, Atlanta, Georgia 30303,1 and Division of Biology, California Institute of Technology, Pasadena, California 911252 Received 27 October 1995/Accepted 3 April 1996 The region of the rubella virus nonstructural open reading frame that contains the papain-like cysteine protease domain and its cleavage site was expressed with a Sindbis virus vector. Cys-1151 has previously been shown to be required for the activity of the protease (L. D. Marr, C.-Y. Wang, and T. K. Frey, Virology 198:586–592, 1994). Here we show that His-1272 is also necessary for protease activity, consistent with the active site of the enzyme being composed of a catalytic dyad consisting of Cys-1151 and His-1272. By means of radiochemical amino acid sequencing, the site in the polyprotein cleaved by the nonstructural protease was found to follow Gly-1300 in the sequence Gly-1299–Gly-1300–Gly-1301. Mutagenesis studies demonstrated that change of Gly-1300 to alanine or valine abrogated cleavage. In contrast, Gly-1299 and Gly-1301 could be changed to alanine with retention of cleavage, but a change to valine abrogated cleavage. Coexpression of a construct that contains a cleavage site mutation (to serve as a protease) together with a construct that contains a protease mutation (to serve as a substrate) failed to reveal trans cleavage. -
Measles and Rubella Initiative Outbreak Response Fund Application Standard Operating Procedures
M&RI SOP Feb 24, 2020 Final Measles and Rubella Initiative Outbreak Response Fund Application Standard Operating Procedures This update of the M&RI ORF Standard Operating Procedures (SOPs) includes the following modifications: 1. To encourage countries to submit applications for ORF support early in the evolution of the outbreak in order to effectively stop measles virus transmission before it becomes more widespread, M&RI will monitor indicators of timeliness of outbreak response immunization in accordance with Immunization Agenda 2030 guidelines; 2. To accelerate the process to receive support, M&RI has removed requirements for advance notification when requesting ORF support and has established a limited timeframe to evaluate the application for ORF support and to provide feedback or issue a decision letter; 3. To more comprehensively address outbreak response linked to timely and efficient use of vaccine, M&RI will allow for greater flexibility in areas of support on an exceptional basis and with adequate justification; 4. To reduce the likelihood of requested additional information or clarifications from M&RI, the SOPs provide greater detail regarding the key data elements and analysis recommended when investigating measles outbreaks and preparing reports, plans and budgets; 5. To maximize use of outbreak investigations and their follow up to strengthen immunization systems, M&RI requests countries to include findings from root cause analyses and, based on these, plans to improve routine immunization, surveillance and outbreak preparedness in the required post-outbreak report. A. Background The Measles and Rubella Initiative (M&RI) has provided funding through an outbreak response fund (ORF) since 2012 to support bundled vaccine and operational costs for measles and rubella outbreak response immunization (ORI), with Gavi supporting up to a total of US$10 million per year for Gavi-eligible countries. -
Understanding Human Astrovirus from Pathogenesis to Treatment
University of Tennessee Health Science Center UTHSC Digital Commons Theses and Dissertations (ETD) College of Graduate Health Sciences 6-2020 Understanding Human Astrovirus from Pathogenesis to Treatment Virginia Hargest University of Tennessee Health Science Center Follow this and additional works at: https://dc.uthsc.edu/dissertations Part of the Diseases Commons, Medical Sciences Commons, and the Viruses Commons Recommended Citation Hargest, Virginia (0000-0003-3883-1232), "Understanding Human Astrovirus from Pathogenesis to Treatment" (2020). Theses and Dissertations (ETD). Paper 523. http://dx.doi.org/10.21007/ etd.cghs.2020.0507. This Dissertation is brought to you for free and open access by the College of Graduate Health Sciences at UTHSC Digital Commons. It has been accepted for inclusion in Theses and Dissertations (ETD) by an authorized administrator of UTHSC Digital Commons. For more information, please contact [email protected]. Understanding Human Astrovirus from Pathogenesis to Treatment Abstract While human astroviruses (HAstV) were discovered nearly 45 years ago, these small positive-sense RNA viruses remain critically understudied. These studies provide fundamental new research on astrovirus pathogenesis and disruption of the gut epithelium by induction of epithelial-mesenchymal transition (EMT) following astrovirus infection. Here we characterize HAstV-induced EMT as an upregulation of SNAI1 and VIM with a down regulation of CDH1 and OCLN, loss of cell-cell junctions most notably at 18 hours post-infection (hpi), and loss of cellular polarity by 24 hpi. While active transforming growth factor- (TGF-) increases during HAstV infection, inhibition of TGF- signaling does not hinder EMT induction. However, HAstV-induced EMT does require active viral replication. -
Diversity and Evolution of Viral Pathogen Community in Cave Nectar Bats (Eonycteris Spelaea)
viruses Article Diversity and Evolution of Viral Pathogen Community in Cave Nectar Bats (Eonycteris spelaea) Ian H Mendenhall 1,* , Dolyce Low Hong Wen 1,2, Jayanthi Jayakumar 1, Vithiagaran Gunalan 3, Linfa Wang 1 , Sebastian Mauer-Stroh 3,4 , Yvonne C.F. Su 1 and Gavin J.D. Smith 1,5,6 1 Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore; [email protected] (D.L.H.W.); [email protected] (J.J.); [email protected] (L.W.); [email protected] (Y.C.F.S.) [email protected] (G.J.D.S.) 2 NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore 119077, Singapore 3 Bioinformatics Institute, Agency for Science, Technology and Research, Singapore 138671, Singapore; [email protected] (V.G.); [email protected] (S.M.-S.) 4 Department of Biological Sciences, National University of Singapore, Singapore 117558, Singapore 5 SingHealth Duke-NUS Global Health Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore 168753, Singapore 6 Duke Global Health Institute, Duke University, Durham, NC 27710, USA * Correspondence: [email protected] Received: 30 January 2019; Accepted: 7 March 2019; Published: 12 March 2019 Abstract: Bats are unique mammals, exhibit distinctive life history traits and have unique immunological approaches to suppression of viral diseases upon infection. High-throughput next-generation sequencing has been used in characterizing the virome of different bat species. The cave nectar bat, Eonycteris spelaea, has a broad geographical range across Southeast Asia, India and southern China, however, little is known about their involvement in virus transmission. -
Diagnosis and Treatment of Orf
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Diagnosis and treatment of orf Author : Graham Duncanson Categories : Farm animal, Vets Date : March 3, 2008 When I used to do a meat inspection for an hour each week, I came across a case of orf in one of the slaughtermen. The lesion was on the back of his hand. The GP thought it was an abscess and lanced the pustule. I was certain it was orf and got some pus into a viral transport medium. The Veterinary Investigation Centre in Norwich confirmed the case as orf and it took weeks to heal. I have always taken the zoonotic aspects of this disease very seriously ever since. When I got a pustule on my finger from my own sheep, I took potentiated sulphonamides by mouth and it healed within three weeks. I always advise clients to wear rubber gloves when dealing with the disease. I also advise any affected people to go to their GP, but not to let the doctor lance the lesion. Virus Orf, which should be called contagious pustular dermatitis, is not a pox virus but a Parapoxvirus. It is allied to viral diseases in cattle, pseudocowpox (caused by the most common virus found on the bovine udder) and bovine papular stomatitis (the oral form of pseudocowpox occurring in young cattle). Both these cattle viruses are self-limiting, rarely causing problems. Sheeppox, which is a Capripoxvirus, is not found in the UK or western Europe. However, it seems to have spread from the Middle East to Hungary. -
Orf, Also Known As Sheep Pox, Is a Common Disease
ORF http://www.aocd.org Orf, also known as sheep pox, is a common disease in sheep-farming regions of the world. Human infection with the orf virus is typically acquired by direct contact with open lesions of an infected animal. However, infection from fomites can also occur due to the virus being resistant to heat and dryness. An infected person will usually have a single nodular lesion at the point of contact, on the hand or forearm. The cause of orf is attributed to the orf virus. This virus is a member of the parapoxvirus genus which also contains milker’s nodule virus. The parapoxvirus genus is a member of the poxviridae family which also includes small pox and cowpox viruses. Orf is considered a zoonotic disease, meaning it affects animals; yet humans can contract the disease from infected sheep and goats. However, the orf virus is not transmitted human-to-human. Occupational acquisition of the disease is the most common means of contraction of the virus. Once a human is infected with the parapoxvirus a nodular lesion will appear. This lesion evolves through several stages. It begins as a papule but then progresses into a lesion with a red center surrounded by a white ring. The lesion then becomes red and weeping. If the lesion is located in an area with hair, temporary alopecia (hair loss) occurs. With further progression, the lesion becomes dry with black spots on the surface. It then flattens and forms a dry crust. The lesion then heals with minimal scarring. The progression of this disease occurs in about 6 weeks. -
Human Papillomavirus and HPV Vaccines: a Review
Human papillomavirus and HPV vaccines: a review FT Cutts,a S Franceschi,b S Goldie,c X Castellsague,d S de Sanjose,d G Garnett,e WJ Edmunds,f P Claeys,g KL Goldenthal,h DM Harper i & L Markowitz j Abstract Cervical cancer, the most common cancer affecting women in developing countries, is caused by persistent infection with “high-risk” genotypes of human papillomaviruses (HPV). The most common oncogenic HPV genotypes are 16 and 18, causing approximately 70% of all cervical cancers. Types 6 and 11 do not contribute to the incidence of high-grade dysplasias (precancerous lesions) or cervical cancer, but do cause laryngeal papillomas and most genital warts. HPV is highly transmissible, with peak incidence soon after the onset of sexual activity. A quadrivalent (types 6, 11, 16 and 18) HPV vaccine has recently been licensed in several countries following the determination that it has an acceptable benefit/risk profile. In large phase III trials, the vaccine prevented 100% of moderate and severe precancerous cervical lesions associated with types 16 or 18 among women with no previous infection with these types. A bivalent (types 16 and 18) vaccine has also undergone extensive evaluation and been licensed in at least one country. Both vaccines are prepared from non-infectious, DNA-free virus-like particles produced by recombinant technology and combined with an adjuvant. With three doses administered, they induce high levels of serum antibodies in virtually all vaccinated individuals. In women who have no evidence of past or current infection with the HPV genotypes in the vaccine, both vaccines show > 90% protection against persistent HPV infection for up to 5 years after vaccination, which is the longest reported follow-up so far. -
Standardization of the Nomenclature for Genetic Characteristics of Wild-Type Rubella Viruses
Standardization of the nomenclature for genetic characteristics of wild-type rubella viruses. A number of genetically distinct groups of rubella viruses currently circulate in the world. The molecular epidemiology of rubella viruses will be primarily useful in rubella control activities for tracking transmission pathways, for documenting changes in the viruses present in particular regions over time, and for documenting interruption of transmission of rubella viruses. Use of molecular epidemiology in control activities is now more relevant since the W HO European Region and the Region of the Americas have adopted congenital rubella infection prevention and elimination goals respectively, targeted for 2010. However, a systematic nomenclature for wild-type rubella viruses has been lacking, which has limited the usefulness of rubella virus genetic data in supporting rubella control activities. A meeting was organized at W HO headquarters on 2-3 September, 2004 to discuss standardization of a nomenclature for describing the genetic characteristics of wild-type rubella viruses. This report is a summary of the outcomes of that meeting. The main goals of the meeting were to provide guidelines for describing the major genetic groups of rubella virus and to establish uniform genetic analysis protocols. In addition, development of a uniform virus naming system, rubella virus strain banks and a sequence database were discussed. Standardization of a nomenclature should allow more efficient communication between the various laboratories conducting molecular characterization of wild-type strains and will provide public health officials with a consistent method for describing viruses associated with cases, outbreaks and epidemics. Epidemiology and logistics Rubella viral surveillance is an important part of rubella surveillance at each phase of rubella control/elimination; the goal should be to obtain a virus sequence from each chain of transmission during the elimination phase or from representative samples from each outbreak during the control phase. -
Document-1.Pdf (100.7Kb)
JOURNAL OF VIROLOGY, Jan. 2004, p. 168–177 Vol. 78, No. 1 0022-538X/04/$08.00ϩ0 DOI: 10.1128/JVI.78.1.168–177.2004 Copyright © 2004, American Society for Microbiology. All Rights Reserved. Genomes of the Parapoxviruses Orf Virus and Bovine Papular Stomatitis Virus G. Delhon,1,2 E. R. Tulman,1 C. L. Afonso,1 Z. Lu,1 A. de la Concha-Bermejillo,3 H. D. Lehmkuhl,4 M. E. Piccone,1 G. F. Kutish,1 and D. L. Rock1* Plum Island Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Greenport, New York 119441; Area of Virology, School of Veterinary Sciences, University of Buenos Aires, 1427 Buenos Aires, Argentina2; Department of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station, Texas 77843-44673; and National Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Downloaded from Ames, Iowa 500104 Received 19 August 2003/Accepted 22 September 2003 Bovine papular stomatitis virus (BPSV) and orf virus (ORFV), members of the genus Parapoxvirus of the Poxviridae, are etiologic agents of worldwide diseases affecting cattle and small ruminants, respectively. Here we report the genomic sequences and comparative analysis of BPSV strain BV-AR02 and ORFV strains OV-SA00, isolated from a goat, and OV-IA82, isolated from a sheep. Parapoxvirus (PPV) BV-AR02, OV-SA00, .and OV-IA82 genomes range in size from 134 to 139 kbp, with an average nucleotide composition of 64% G؉C BPSV and ORFV genomes contain 131 and 130 putative genes, respectively, and share colinearity over 127 http://jvi.asm.org/ genes, 88 of which are conserved in all characterized chordopoxviruses. -
Arenaviridae Astroviridae Filoviridae Flaviviridae Hantaviridae
Hantaviridae 0.7 Filoviridae 0.6 Picornaviridae 0.3 Wenling red spikefish hantavirus Rhinovirus C Ahab virus * Possum enterovirus * Aronnax virus * * Wenling minipizza batfish hantavirus Wenling filefish filovirus Norway rat hunnivirus * Wenling yellow goosefish hantavirus Starbuck virus * * Porcine teschovirus European mole nova virus Human Marburg marburgvirus Mosavirus Asturias virus * * * Tortoise picornavirus Egyptian fruit bat Marburg marburgvirus Banded bullfrog picornavirus * Spanish mole uluguru virus Human Sudan ebolavirus * Black spectacled toad picornavirus * Kilimanjaro virus * * * Crab-eating macaque reston ebolavirus Equine rhinitis A virus Imjin virus * Foot and mouth disease virus Dode virus * Angolan free-tailed bat bombali ebolavirus * * Human cosavirus E Seoul orthohantavirus Little free-tailed bat bombali ebolavirus * African bat icavirus A Tigray hantavirus Human Zaire ebolavirus * Saffold virus * Human choclo virus *Little collared fruit bat ebolavirus Peleg virus * Eastern red scorpionfish picornavirus * Reed vole hantavirus Human bundibugyo ebolavirus * * Isla vista hantavirus * Seal picornavirus Human Tai forest ebolavirus Chicken orivirus Paramyxoviridae 0.4 * Duck picornavirus Hepadnaviridae 0.4 Bildad virus Ned virus Tiger rockfish hepatitis B virus Western African lungfish picornavirus * Pacific spadenose shark paramyxovirus * European eel hepatitis B virus Bluegill picornavirus Nemo virus * Carp picornavirus * African cichlid hepatitis B virus Triplecross lizardfish paramyxovirus * * Fathead minnow picornavirus